Trademark Overview
On Wednesday, April 24, 2024, a trademark application was filed for VIANAUTIS with the United States Patent and Trademark Office. The USPTO has given the VIANAUTIS trademark a serial number of 98516669. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, November 15, 2024. This trademark is owned by VIANAUTIS BIO LIMITED. The VIANAUTIS trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations; reagents, diagnostics, prophylactics and therapeutic preparations for use in conditions of the central and peripheral nervous systems, diseases of the lung, kidney, liver or any peripheral organs, and oncology; vaccines; therapeutic preparations for use in treating diseases of the central and peripheral nervous systems, diseases of lung, kidney, liver or other organs, and cancer in medical and veterinary patients; targeted preparations for treating diseases of the central and peripheral nervous systems, diseases of lung, kidney, liver or other organs, or cancer; medical and veterinary preparations for use in central and peripheral nervous system diseases, diseases of the lung, kidney, liver and other organs, and cancer; medical and veterinary preparations for the delivery of compounds to the brain; medical and veterinary preparations for crossing the blood-brain barrier and other biological barriers; medical and veterinary preparations for delivering reagen...
Chemicals used in science; chemicals for encapsulating, microencapsulating and decapsulating other chemicals; chemicals for the protection, delivery, transport and triggered or controlled release of other chemicals; chemicals for encapsulating, microencapsulating and decapsulating biologically active ingredients including enzymes and cells.
Scientific and technological services and research and design relating thereto; industrial analysis and research services; medical and veterinary research services; scientific research in the development of new therapies and new methods for delivering therapies; scientific research into nanoparticles; scientific research into encapsulation, microencapsulation and de-capsulation of reagents, diagnostics, prophylactics and therapeutics; scientific research into crossing the blood brain barrier and other biological barriers; scientific research into nano-engineering for intracellular delivery; consultancy relating to all the aforesaid services.
